LL-37, the only human member of the cathelicidin family of antimicrobial peptides

Biochimica et Biophysica Acta - Biomembranes

Volumn 1758, Issue 9, 2006, Pages 1408-1425

  Dürr, Ulrich H N ^a   Sudheendra, U S ^a   Ramamoorthy, Ayyalusamy ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Antibiotic; Antimicrobial peptide; Cathelicidin; LL 37; Membrane; Solid state NMR

Indexed keywords

LIPOPOLYSACCHARIDE; PEPTIDE DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT;

ANGIOGENESIS; CIRCULAR DICHROISM; CYTOTOXICITY; DRUG ACTIVITY; GENE EXPRESSION; GENE MUTATION; INNATE IMMUNITY; MAMMAL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYLOGENY; PRIORITY JOURNAL; REVIEW; WOUND HEALING;

AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; IMMUNITY, NATURAL; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA;

MAMMALIA;

EID: 33748935159     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2006.03.030     Document Type: Review

References (213)

1. Brogden K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev., Microbiol. 3 (2005) 238-250
2. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
3. Boman H.G. Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med. 254 (2003) 197-215
4. Elsbach P. What is the real role of antimicrobial polypeptides that can mediate several other inflammatory responses?. J. Clin. Invest. 111 (2003) 1643-1645
5. Hancock R.E., and Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8 (2000) 402-410
6. Hancock R.E. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1 (2001) 156-164
7. De Smet K., and Contreras R. Human antimicrobial peptides: defensins, cathelicidins and histatins. Biotechnol. Lett. 27 (2005) 1337-1347
8. Bardan A., Nizet V., and Gallo R.L. Antimicrobial peptides and the skin. Expert Opin. Biol. Ther. 4 (2004) 1-7
9. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75 (2004) 39-48
10. Bals R., and Wilson J.M. Cathelicidins-A family of multifunctional antimicrobial peptides. Cell. Mol. Life Sci. 60 (2003) 711-720
11. Gennaro R., Skerlavaj B., and Romeo D. Purification, composition, and activity of two Bactenectins, antibacterial peptides of bovine neutrophils. Infect. Immun. 57 (1989) 3142-3146
12. Zanetti M., Litteri L., Gennaro R., Horstmann H., and Romeo D. Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large granules. J. Cell Biol. 111 (1990) 1363-1371
13. Frank R.W., Gennaro R., Schneider K., Przybylski M., and Romeo D. Amino acid sequences of two proline-rich bactenectins. J. Biol. Chem. 265 (1990) 18871-18874
14. Zanetti M., Del Sal G., Storici P., Schneider C., and Romeo D. The cDNA of the neutrophil antibiotic Bac5 predicts a pro-sequence homologous to a cysteine proteinase inhibitor that is common to other neutrophil antibiotics. J. Biol. Chem. 268 (1993) 522-526
15. Zanetti M., Gennaro R., and Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374 (1995) 1-5
16. Gennaro R., and Zanetti M. Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 55 (2000) 31-49
17. Ritonja A., Kopitar M., Jerala R., and Turk V. Primary structure of a new cysteine proteinase inhibitor from pig leukocytes. FEBS Lett. 255 (1989) 211-214
18. Storici P., Tossi A., Lenarcic B., and Romeo D. Purification and structural characterization of bovine cathelicidins, precursors of antimicrobial peptides. Eur. J. Biochem. 238 (1996) 769-776
19. Scocchi M., Wang S., and Zanetti M. Structural organization of the bovine cathelicidin gene family and identification of a novel member. FEBS Lett. 417 (1997) 311-315
20. Dubin G. Proteinaceous cysteine protease inhibitors. Cell. Mol. Life Sci. 62 (2005) 653-669
21. Larrick J.W., Lee J., Ma S., Li X., Francke U., Wright S.C., and Balint R.F. Structural, functional analysis and localization of the human CAP18 gene. FEBS Lett. 398 (1996) 74-80
22. Xiao Y., Cai Y., Bommineni Y.R., Fernando S.C., Prakash O., Gilliland S.E., and Zhang G. Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity. J. Biol. Chem. 281 (2006) 2858-2867
23. Chang C.-I., Pleguezuelos O., Zhang Y.-A., Zou J., and Secombes C.J. Identification of a novel cathelicidin gene in the rainbow trout, Oncorhynchus mykiss. Infect. Immun. 73 (2005) 5053-5064
24. Chang C.-I., Zhang Y.-A., Zou J., Nie P., and Secombes C.J. Two cathelicidin genes are present in both rainbow trout (Oncorhynchus mykiss) and atlantic salmon (Salmo salar). Antimicrob. Agents Chemother. 50 (2006) 185-195
25. Uzzell T., Stolzenberg E.D., Shinnar A.E., and Zasloff M. Hagfish intestinal antimicrobial peptides are ancient cathelicidins. Peptides 24 (2003) 1655-1667
26. Raison R.L., and dos Remedios N.J. The hagfish immune system. In: Jorgensen J.M., Lomholt J.P., Weber R.E., and Malte H. (Eds). The Hagfish Immune System (1998), Chapman and Hall 334-344
27. Bals R., Lang C., Weiner D.J., Vogelmeier C., Welsch U., and Wilson J.M. Rhesus monkey (Macaca mulatta) mucosal antimicrobial peptides are close homologues of human molecules. Clin. Diagn. Lab. Immunol. 8 (2001) 370-375
28. Zhao C., Nguyen T., Boo L.M., Hong T., Espiritu C., Orlov D., Wang W., Waring A., and Lehrer R.I. RL-37, an alpha-helical antimicrobial peptide of the rhesus monkey. Antimicrob. Agents Chemother. 45 (2001) 2695-2702
29. Gallo R.L., Kim K.J., Bernfield M., Kozak C.A., Zanetti M., Merluzzi L., and Gennaro R. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J. Biol. Chem. 272 (1997) 13088-13093
30. Termén S., Tollin M., Olsson B., Svenberg T., Agerberth B., and Gudmundsson G.H. Phylogeny, processing and expression of the rat Cathelicidin rCRAMP: a model for innate antimicrobial peptides. Cell. Mol. Life Sci. 60 (2003) 536-549
31. Nagaoka I., Tsutsumi-Ishii Y., Yomogida S., and Yamashita T. Isolation of cDNA encoding guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and evaluation of CAP11 mRNA expression during neutrophil maturation. J. Biol. Chem. 272 (1997) 22742-22750
32. Agerberth B., Gunne H., Odeberg J., Kogner P., Boman H.G., and Gudmundsson G.H. FALL-37, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 195-199
33. Larrick J.W., Hirata M., Balint R.F., Lee J., Zhong J., and Wright S.C. Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 63 (1995) 1291-1297
34. Cowland J.B., Johnsen A.H., and Borregaard N. hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett. 368 (1995) 173-176
35. Gudmundsson G.H., Agerberth B., Odeberg J., Bergman T., Olsson B., and Salceldo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238 (1996) 325-332
36. Sorensen O.E., Bratt T., Johnsen A.H., Madsen M.T., and Borregaard N. The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma. J. Biol. Chem. 274 (1999) 22445-22451
37. Zarember K.A., Katz S.S., Tack B.F., Doukhan L., Weiss J., and Elsbach P. Host defense functions of proteolytically processed and parent (unprocessed) cathelicidins of rabbit granulocytes. Infect. Immun. 70 (2002) 569-576
38. Scocchi M., Skerlavaj B., Romeo D., and Gennaro R. Proteolytic cleavage by neutrophil elastase converts inactive storage proforms to antibacterial bactenecins. Eur. J. Biochem. 209 (1992) 589-595
39. Panyutich A., Shi J., Boutz P.L., Zhao C., and Ganz T. Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infect. Immun. 65 (1997) 978-985
40. Sorensen O.E., Follin P., Johnsen A.H., Calafat J., Tjabringa G.S., Hiemstra P.S., and Borregaard N. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97 (2001) 3951-3959
41. Sorensen O.E., Gram L., Johnsen A.H., Andersson E., Bangsboll S., Tjabringa G.S., Hiemstra P.S., Malm J., Egesten A., and Borregaard N. Processing of seminal plasma hCAP-18 to ALL-38 by Gastricsin. J. Biol. Chem. 278 (2003) 28540-28546
42. Murakami M., Lopez-Garcia B., Braff M.H., Dorschner R.A., and Gallo R.L. Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense. J. Immunol. 172 (2004) 3070-3077
43. Sanchez J.-F., Hoh F., Strub M.-P., Aumelas A., and Dumas C. Structure of the cathelicidin motif of protegrin-3 precursor: Structural insights into the activation mechanism of an antimicrobial protein. Structure 10 (2002) 1363-1370
44. Yang Y., Sanchez J.F., Strub M.-P., Brutscher B., and Aumelas A. NMR Structure of the cathelin-like domain of the protegrin-3 precursor. Biochemistry 42 (2003) 4669-4680
45. Fahrner R.L., Dieckmann T., Harwig S.S., Lehrer R.I., Eisenberg D., and Feigon J. Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem. Biol. 3 (1996) 543-550
46. Aumelas A., Mangoni M., Roumestand C., Chiche L., Despaux E., Grassy G., Calas B., and Chavanieu A. Synthesis and solution structure of the antimicrobial peptide protegrin-1. Eur. J. Biochem. 237 (1996) 575-583
47. Zaiou M., Nizet V., and Gallo R.L. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J. Invest. Dermatol. 120 (2003) 810-816
48. Ramanathan B., Davis E.G., Ross C.R., and Blecha F. Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes Infect. 4 (2002) 361-372
49. Shinnar A.E., Uzzell T., Rao M.N., Spooner E., Lane W.S., and Zasloff M. New family of linear antimicrobial peptides from hagfish intestine contains bromo-tryptophan as novel amino acid. In: Kaumaya P., and Hodges R. (Eds). Peptides: Chemistry and Biology. Proceedings of the 14th American Peptide Symposium (1996), Mayflower Scientific Ltd, Leiden 189-191
50. Shamova O., Brogden K.A., Zhao C., Nguyen T., Kokryakov V.N., and Lehrer R.I. Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes. Infect. Immun. 67 (1999) 4106-4111
51. Johansson J., Gudmundsson G.H., Rottenberg M.E., Berndt K.D., and Agerberth B. Conformation-dependent antibacterial activity of the naturally occuring human peptide LL-37. J. Biol. Chem. 273 (1998) 3718-3724
52. Chen C., Brock R., Luh F., Chou P.-J., Larrick J.W., Huang R.-F., and Huang T. The solution structure of the active domain of CAP18-A lipopolysaccharide binding protein from rabbit leukocytes. FEBS Lett. 370 (1995) 46-52
53. Borregaard N., Theilgaard-Mönch K., Sorensen O.E., and Cowland J.B. Regulation of human neutrophil granule protein expression. Curr. Opin. Hematol. 8 (2001) 23-27
54. Nagaoka I., Hirata M., Sugimoto K., Tsutsumi-Ishii Y., Someya A., Saionji K., and Igari J. Evaluation of the expression of human CAP18 gene during neutrophil maturation in the bone marrow. J. Leukoc. Biol. 64 (1998) 845-852
55. Bülow E., Bengtsson N., Calafat J., Gullberg U., and Olsson I. Sorting of neutrophil-specific granule protein human cathelicidin, hCAP-18, when constitutively expressed in myeloid cells. J. Leukoc. Biol. 72 (2002) 147-153
56. Wang Y., Agerberth B., Löthgren A., Almstedt A., and Johansson J. Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J. Biol. Chem. 273 (1998) 33115-33118
57. Wang Y., Johansson J., Agerberth B., Jörnvall H., and Griffiths W.J. The antimicrobial peptide LL-37 binds to the human plasma protein apolipoprotein A-I. Rapid Commun. Mass Spectrom. 18 (2004) 588-589
58. Paulsen F.P., Pufe T., Schaudig U., Held-Feindt J., Lehmann J., Schröder J.-M., and Tillmann B.N. Detection of natural peptide antibiotics in human nasolacrimal ducts. Invest. Ophthalmol. Vis. Sci. 42 (2001) 2157-2163
59. Nell M.J., Sandra T.G., Vonk M.J., Hiemstra P.S., and Grote J.J. Bacterial products increase expression of the human cathelicidin hCAP-18/LL-37 in cultured human sinus epithelial cells. FEMS Immunol. Med. Microbiol. 42 (2004) 225-231
60. Stroingg N., and Srivastava M.D. Modulation of toll-like receptor 7 and LL-37 expression in colon and breast epithelial cells by human beta-defensin 2. Allergy Asthma Proc. 26 (2005) 299-309
61. Heilborn J.D., Nilsson M.F., Kratz G., Weber G., Sorensen O., Borregaard N., and Stahle-Backdahl M. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120 (2003) 379-389
62. Howell M.D., Novak N., Bieber T., Pastore S., Girolomoni G., Boguniewicz M., Streib J., Wong C., Gallo R.L., and Leung D.Y.M. Interleukin-10 downregulates anti-microbial peptide expression in atopic dermatitis. J. Invest. Dermatol. 125 (2005) 738-745
63. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., Gallo R.L., and Leung D.Y. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347 (2005) 1151-1160
64. Islam D., Bandholtz L., Nilsson J., Wigzell H., Christensson B., Agerberth B., and Gudmundsson G.H. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7 (2001) 180-185
65. Pütsep K., Carlsson G., Boman H., and Andersson M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360 (2005) 1144-1149
66. Bals R., Weiner D.J., Meegalla R.L., and Wilson J.M. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J. Clin. Invest. 103 (1999) 1113-1117
67. Tjabringa G.S., Rabe K.F., and Hiemstra P.S. The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung. Pulm. Pharmacol. Ther. 18 (2005) 321-327
68. Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindblom L., Kiessling R., Jornvall H., Wigzell H., and Gudmundsson G.H. The human antimicrobial and chemotactic peptides LL-37 and beta-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96 (2000) 3086-3093
69. + NK/T cell line. Leuk. Res. 29 (2005) 813-820
70. Sorensen O., Arnljots K., Cowland J.B., Bainton D.F., and Borregaard N. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90 (1997) 2796-2803
71. Armogida S.A., Yannaras N.M., Melton A.L., and Srivastava M.D. Identification and quantification of innate immune system mediators in human breast milk. Allergy Asthma Proc. 25 (2004) 297-304
72. Murakami M., Dorschner R.A., Stern L.J., Lin K.H., and Gallo R.L. Expression and secretion of cathelicidin antimicrobial peptides in murine mammary glands and human milk. Pediatr. Res. 57 (2004) 10-15
73. Dorschner R.A., Lin K.H., Murakami M., and Gallo R.L. Neonatal skin in mice and humans expresses increased levels of antimicrobial peptides: innate immunity during development of the adaptive response. Pediatr. Res. 53 (2003) 566-572
74. Marchini G., Lindow S., Brismar H., Ståbi B., Berggren V., Ulfgren A.-K., Lonne-Rahm S., Agerberth B., and Gudmundsson G.H. The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa. Br. J. Dermatol. 147 (2002) 1127-1134
75. Frohm N.M., Sandstedt B., Sorensen O.E., Weber G., Borregaard N., and Stahle-Backdahl M. The human cationic antimicrobial protein (hCAP-18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect. Immun. 67 (1999) 2561-2566
76. Dorschner R.A., Lopez-Garcia B., Massie J., Kim C., and Gallo R.L. Innate immune defense of the nail unit by antimicrobial peptides. J. Am. Acad. Dermatol. 50 (2004) 343-348
77. Murakami M., Ohtake T., Dorschner R.A., Schittek B., Garbe C., and Gallo R.L. Cathelicidin antimicrobial peptide expression in sweat, an innate defense system for the skin. J. Invest. Dermatol. 119 (2002) 1090-1095
78. Frohm M., Gunne H., Bergman A.C., Agerberth B., Bergman T., Boman A., Liden S., Jornvall H., and Boman H.G. Biochemical and antibacterial analysis of human wound and blister fluid. Eur. J. Biochem. 237 (1996) 86-92
79. Gordon Y.J., Huang L.C., Romanowski E.G., Yates K.A., Proske R.J., and McDermott A.M. Human cathelicidin (LL-37), a multifunctional peptide, is expressed by ocular surface epithelia and has potent antibacterial and antiviral activity. Curr. Eye Res. 30 (2005) 385-394
80. Paulsen F., Pufe T., Conradi L., Varoga D., Tsokos M., Papendieck J., and Petersen W. Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes. J. Pathol. 198 (2002) 369-377
81. Chen P.H., and Fang S.Y. The expression of human antimicrobial peptide LL-37 in the human nasal mucosa. Am. J. Rhinol. 18 (2004) 381-385
82. Bals R., Wang X., Zasloff M., and Wilson J.M. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9541-9546
83. Starner T.D., Agerberth B., Gudmundsson G.H., and McCray Jr. P.B. Expression and activity of β-defensins and LL-37 in the developing human lung. J. Immunol. 174 (2005) 1608-1615
84. Agerberth B., Grunewald J., Castanos-Velez E., Olsson B., Jornvall H., Wigzell H., Eklund A., and Gudmundsson G.H. Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients. Am. J. Respir. Crit. Care Med. 160 (1999) 283-290
85. Murakami M., Ohtake T., Dorschner T., and Gallo R.L. Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J. Dent. Res. 81 (2002) 845-850
86. Woo J.S., Jeong J.Y., Hwang Y.J., Chae S.W., Hwang S.J., and Lee H.M. Expression of cathelicidin in human salivary glands. Arch. Otolaryngol. Head Neck Surg. 129 (2005) 211-214
87. Dale B.A., Kimball J.R., Krisanaprakornkit S., Roberts F., Robinovitch M., O'Neal R., Valore E.V., Ganz T., Anderson G.M., and Weinberg A. Localized antimicrobial peptide expression in human gingiva. J. Periodontal Res. 36 (2001) 285-294
88. Hase K., Eckmann L., Leopard J.D., Varki N., and Kagnoff M.F. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun. 70 (2002) 953-963
89. Tollin M., Bergman P., Svenberg T., Jörnvall H., Gudmundsson G.H., and Agerberth B. Antimicrobial peptides in the first line defence of human colon mucosa. Peptides 24 (2003) 523-530
90. Malm J., Sorensen O., Persson T., Frohm-Nilsson M., Johansson B., Bjartell A., Lilja H., Stahle-Backdahl M., Borregaard N., and Egesten A. The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma, and is attached to spermatozoa. Infect. Immun. 68 (2000) 4297-4302
91. Andersson E., Sorensen O.E., Frohm B., Borregaard N., Egesten A., and Malm J. Isolation of human cationic antimicrobial protein-18 from seminal plasma and its association with prostasomes. Hum. Reprod. 17 (2002) 2529-2534
92. Yoshio H., Tollin M., Gudmundsson G.H., Lagercrantz H., Jornvall H., Marchini G., and Agerberth B. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: Implications for newborn innate defense. Pediatr. Res. 53 (2005) 211-216
93. Akinbi H.T., Narendran V., Kun Pass A., Markart P., and Hoath S.B. Host defense proteins in vernix caseosa and amniotic fluid. Am. J. Obstet. Gynecol. 191 (2004) 2090-2096
94. Tollin M., Bergsson G., Kai-Larsen Y., Lengquist J., Sjövall J., Griffith W., Skúladóttir G.V., Haraldson Á., Jörnvall H., Gudmundsson G.H., and Agerberth B. Vernix caseosa as a multi-component defence system based on polypeptides, lipids and their interactions. Cell. Mol. Life Sci. 62 (2005) 2390-2399
95. Frohm M., Agerberth B., Ahangari G., Stahle-Backdahl M., Liden S., Wigzell H., and Gudmundsson G.H. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272 (1997) 15258-15263
96. Li D., Li J., Duan Y., and Zhou X. Expression of LL-37, a human beta defensin-2, and CCR6 mRNA in patients with psoriasis vulgaris. J. Huazhong Univ. Sci. Technol. Med. Sci. 24 (2004) 404-406
97. Kim J.E., Kim B.J., Jeong M.S., Seo S.J., Kim M.N., Hong C.K., and Ro B.I. Expression and modulation of LL-37 in normal human keratinocytes, HaCaT cells, and inflammatory skin diseases. J. Korean Med. Sci. 20 (2005) 649-654
98. Hase K., Murakami M., Iimura M., Cole S.P., Horibe Y., Ohtake T., Obonyo M., Gallo R.L., Eckmann L., and Kagnoff M.F. Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 125 (2003) 1613-1625
99. Kim S.T., Cha H.E., Kim D.Y., Han G.C., Chung Y.S., Lee Y.J., Hwang Y.J., and Lee H.M. The antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease. Acta Oto-Laryngol. 123 (2003) 81-85
100. Chen C.I.U., Schaller-Bals S., Paul K.P., Wahn U., and Bals R. β-defensins and LL-37 in bronchoalveolar lavage fluid of patients with cystic fibrosis. J. Cyst. Fibros. 3 (2004) 45-50
101. Schaller-Bals S., Schulze A., and Bals R. Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am. J. Respir. Crit. Care Med. 165 (2002) 992-995
102. Heilborn J.D., Frohm-Nilsson M., Chamorro Jimenez C.I., Sandstedt B., Borregaard N., Tham E., Sorensen O.E., Weber G., and Stahle M. Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. Int. J. Cancer 114 (2005) 713-719
103. Conner K., Nern K., Rudisill J., O'Grady T., and Gallo R.L. The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris. J. Am. Acad. Dermatol. 47 (2005) 347-350
104. Jung H.H., Chae S.W., Jung S.K., Kim S.T., Lee H.M., and Hwang S.J. Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma. Laryngoscope 113 (2005) 432-435
105. An L.-L., Ma X.-T., Yang Y.-H., Lin Y.-M., Song Y.-H., and Wu K.-F. Marked reduction of LL-37/hCAP-18, an antimicrobial peptide, in patients with acute myeloid leukemia. Int. J. Hematol. 81 (2005) 45-47
106. Yang Y.-H., Zheng G.-G., Li G., Zhang B., Song Y.-H., and Wu K.-F. Expression of LL-37/hCAP-18 gene in human leukemia cells. Leuk. Res. 27 (2003) 947-950
107. Turner J., Cho Y., Dinh N.-N., Waring A., and Lehrer R.I. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42 (1998) 2206-2214
108. Larrick J.W., Hirata M., Zhong J., and Wright S.C. Anti-microbial activity of human CAP18 peptides. Immunotechnology 1 (1995) 65-72
109. Tanaka D., Miyasaki K.T., and Lehrer R.I. Sensitivity of Actinobacillus actinomcetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium. Oral Microbiol. Immunol. 15 (2000) 226-231
110. Yasin B., Pang M., Turner J.S., Cho Y., Dinh N.-N., Waring A.J., Lehrer R.I., and Wagar E.A. Evaluation of the inactivation of infectious herpes simplex virus by host-defense peptides. Eur. J. Clin. Microbiol. Infect. Dis. 19 (2000) 187-194
111. Howell M.D., Jones J.F., Kisich K.O., Streib J.E., Gallo R.L., and Leung D.Y. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J. Immunol. 172 (2004) 1763-1767
112. den Hertog A.L., van Marle J., van Veen H.A., van't Hoff W., Bolscher J.G.M., Veerman E.C.I., and Nieuw Amerongen A.V. Candidacidal effects of two antimicrobial peptides: histatin 5 causes small membrane defects, but LL-37 causes massive disruption of the cell membrane. Biochem. J. 388 (2005) 689-695
113. López-Garcia B., Lee P.H.A., Yamasaki K., and Gallo R.L. Anti-fungal activity of cathelicidins and their potential role in Candida albicans skin infection. J. Invest. Dermatol. 125 (2005) 108-115
114. Pietiäinen M., Gardemeister M., Mecklin M., Leskelä S., Sarvas M., and Kontinen V.P. Cationic antimicrobial peptides elicit a complex stress response in Bacillus subtilis that involves ECF-type sigma factors and two-component signal transduction systems. Microbiology 151 (2005) 1577-1592
115. Sambri V., Marangoni A., Giacani L., Gennaro R., Murgia R., Cevenini R., and Cinco M. Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia, and Treponema pallidum. J. Antimicrob. Chemother. 50 (2002) 895-902
116. Dorschner R.A., Pestonjamasp V.K., Tamakuwala S., Ohtake T., Rudisill J., Nizet V., Agerberth B., Gudmundsson G.H., and Gallo R.L. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A streptococcus. J. Invest. Dermatol. 117 (2001) 91-97
117. Lusitani D., Malawista S.E., and Montgomery R.R. Borrelia burgdorferi are susceptible to killing by a variety of human polymorphonuclear leukocyte components. J. Infect. Dis. 185 (2002) 797-804
118. Cox D.L., Sun Y., Liu H., Lehrer R.I., and Shafer W.M. Susceptibility of Treponema pallidum to host-derived antimicrobial peptides. Peptides 24 (2003) 1741-1746
119. Travis S.M., Anderson N.N., Forsyth W.R., Espiritu C., Conway B.D., Greenberg E.P., McCray Jr. P.B., Lehrer R.I., Welsh M.J., and Tack B.F. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect. Immun. 68 (2000) 2748-2755
120. Wang Y., Walter G., Herting E., Agerberth B., and Johansson J. Antibacterial activities of the cathelicidins prophenin (residues 62 to 79) and LL-37 in the presence of a lung surfactant preparation. Antimicrob. Agents Chemother. 48 (2004) 2097-2100
121. Huang L.C., Jean D., and McDermott A.M. Effect of preservative-free artificial tears on the antimicrobial activity of human beta-defensin-2 and cathelicidin LL-37 in vitro. Eye Contact Lens 31 (2005) 34-38
122. Jacobsen F., Mittler D., Hirsch T., Gerhards A., Lehnhardt M., Voss B., Steinau H.U., and Steinstraesser L. Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections. Gene Ther. 12 (2005) 1494-1502
123. Bals R., Weiner D.J., Moscioni A.D., Meegalla R.L., and Wilson J.M. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect. Immun. 67 (1999) 6084-6089
124. Nizet V., Ohtake T., Lauth X., Trowbridge J., Rudisill J., Dorschner R.A., Pestonjamasp V., Piraino J., Huttner K., and Gallo R.L. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414 (2001) 454-457
125. Braff M.H., Zaiou M., Fierer J., Nizet V., and Gallo R.L. Keratinocyte production of cathelicidin provides direct activity against bacterial skin pathogens. Infect. Immun. 73 (2005) 6771-6781
126. Lee P.H.A., Ohtake T., Zaiou M., Murakami M., Rudisill J.A., Lin K.H., and Gallo R.L. Expression of an additional cathelicidin antimicrobial peptide protects against bacterial skin infection. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3750-3755
127. Bowdish D.M.E., Davidson D.J., Lau Y.E., Lee K., Scott M.G., and Hancock R.E.W. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 77 (2005) 451-459
128. Erdag G., and Morgan J.R. Interleukin-1α and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts. Ann. Surg. 235 (2002) 113-124
129. Schauber J., Iffland K., Frisch S., Kudlich T., Schmausser B., Eck M., Menzel T., Gostner A., Lührs H., and Scheppach W. Histone-deacetylase inhibitors induce the cathelicidin LL-37 in gastrointestinal cells. Mol. Immunol. 41 (2004) 847-854
130. Schauber J., Svanholm C., Termén S., Iffland K., Menzel T., Scheppach W., Melcher R., Agerberth B., Lührs H., and Gudmundsson G.H. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut 52 (2003) 735-741
131. Lysenko E.S., Gould J., Bals R., Wilson J.M., and Weiser J.N. Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. Infect. Immun. 68 (2000) 1664-1671
132. Nyberg P., Rasmussen M., and Björck L. α2-macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37. J. Biol. Chem. 279 (2004) 52820-52823
133. Schmidtchen A., Frick I.-M., Andersson E., Tapper H., and Björck L. Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 46 (2002) 157-168
134. Belas R., Manos J., and Suvanasuthi R. Proteus mirabilis ZapA metalloproteinase degrades a broad spectrum of substrates, including antimicrobial peptides. Infect. Immun. 72 (2004) 5159-5167
135. Sieprawska-Lupa M., Mydel P., Krawczyk K., Wójcik K., Puklo M., Lupa B., Suder P., Silberring J., Reed M., Pohl J., Shafer W., McAleese F., Foster T., Travis J., and Potempa J. Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48 (2004) 4673-4679
136. Werthén M., Davoudi M., Sonesson A., Nitsche D.P., Mörgelin M., Blom K., and Schmidtchen A. Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer. J. Antimicrob. Chemother. 54 (2004) 772-779
137. Fernie-King B.A., Seilly D.J., and Lachmann P.J. The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins. Immunology 111 (2004) 444-452
138. Frick I.-M., Åkeson P., Rasmussen M., Schmidtchen A., and Björck L. SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J. Biol. Chem. 278 (2003) 16561-16566
139. McPhee J.B., Lewenza S., and Hancock R.E.W. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol. Microbiol. 50 (2003) 205-217
140. Shafer W.M., Qu X.-D., Waring A.J., and Lehrer R.I. Modulation of Neisseria gonorhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 1829-1833
141. Bergman P., Johansson L., Asp V., Plant L., Gudmundsson G.H., Jonsson A.-B., and Agerberth B. Neisseria gonorhoeae downregulates expression of the human antimicrobial peptide LL-37. Cell. Microbiol. 7 (2005) 1009-1017
142. Tzeng Y.-L., Ambrose K.D., Zughaier S.M., Zhou X., Miller Y.K., Shafer W.M., and Stephens D.S. Cationic antimicrobial peptide resistance in Neisseria meningitidis. J. Bacteriol. 187 (2005) 5387-5396
143. Samuelsen Ø., Haukland H.H., Jenssen H., Krämer M., Sandvik K., Ulvatne H., and Vorland L.H. Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus. FEBS Lett. 579 (2005) 3421-3426
144. Oren Z., Lerman J.C., Gudmundsson G.H., Agerberth B., and Shai Y. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem. J. 341 (1999) 501-513
145. Nagaoka I., Hirota S., Yomogida S., Ohwada A., and Hirata M. Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm. Res. 49 (2000) 73-79
146. Chen X., Niyonsaba F., Ushio H., Okuda D., Nagaoka I., Ikeda S., Okumura K., and Ogawa H. Synergistic effect of antibacterial agents human β-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. J. Dermatol. Sci. 40 (2005) 123-132
147. Singh P.K., Tack B.F., McCray Jr. P.B., and Welsh M.J. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am. J. Physiol., Lung Cell. Mol. Physiol. 279 (2000) L799-L805
148. Y. Li, X. Li, G. Wang. Cloning, expression, isotope labeling, and purification of human antimicrobial peptide LL-37 in Escherichia coli for NMR studies. Prot. Expr. Purif. (in press).
149. Yang Y.-H., Zheng G.-G., Li G., Zhang X.-J., Cao Z.-Y., Rao Q., and Wu K.-F. Expression of bioactive recombinant GSLL-39, a variant of human antimicrobial peptide LL-37, in Escherichia coli. Protein. Expr. Purif. 37 (2004) 229-235
150. K.A. Henzler Wildman, PhD Thesis. The mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37, (2003). University of Michigan, Ann Arbor.
151. Tossi A., Scocchi M., Skerlavaj B., and Gennaro R. Identification and characterization of a primary antibacterial domain in CAP18, a lipopolysaccharide binding protein from rabbit leukocytes. FEBS Lett. 339 (1994) 108-112
152. Scott M.G., Davidson D.J., Gold M.R., Bowdish D., and Hancock R.E. The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune response. J. Immunol. 169 (2002) 3883-3891
153. Larrick J.W., Hirata M., Zheng H., Zhong J., Bolin D., Cavaillon J.M., Warren H.S., and Wright S.C. A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J. Immunol. 152 (1994) 231-240
154. Scott M.G., and Hancock R.E. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit. Rev. Immunol. 20 (2002) 407-431
155. Hirata M., Shimomura Y., Yoshida M., Morgan J.G., Palings I., Wilson D., Yen M.H., and Wright S.C. Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect. Immun. 62 (1994) 1421-1426
156. Herasimenka Y., Benincasa M., Mattiuzzo M., Cescutti P., Gennaro R., and Rizzo R. Interaction of antimicrobial peptides with bacterial polysaccharides from lung pathogens. Peptides 26 (2005) 1127-1132
157. Rosenfeld Y., Papo N., and Shai Y. Endotoxin (LPS) neutralization by innate immunity host-defense peptides: peptides' properties and plausible modes of action. J. Biol. Chem. 281 (2006) 1636-1643
158. Zughaier S.M., Shafer W.M., and Stephens D.S. Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Cell. Microbiol. 7 (2005) 1251-1262
159. Bowdish D.M.E., Davidson D.J., Scott M.G., and Hancock R.E.W. Immunomodulatory activities of small host defense peptides. Antimicrob. Agents Chemother. 49 (2005) 1727-1732
160. Ciornei C.D., Egesten A., and Bodelsson M. Effects of human cathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro. Acta Anaesthesiol. Scand. 47 (2003) 213-220
161. Tack B.F., Sawai M.V., Kearney W.R., Robertson A.D., Sherman M.A., Wang W., Hong T., Boo L.M., Wu H., Waring A.J., and Lehrer R.I. SMAP-29 has two LPS-binding sites and a central hinge. Eur. J. Biochem. 269 (2002) 1181-1189
162. Hoess A., Watson S., Siber G.R., and Liddington R. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5A resolution. EMBO J. 12 (1993) 3351-3356
163. Nagaoka I., Hirota S., Niyonsaba F., Hirata M., Adachi Y., Tamura H., Tanaka S., and Heumann D. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin. Diagn. Lab. Immunol. 9 (2002) 972-982
164. Fukumoto K., Nagaoka I., Yamataka A., Kobayashi H., Yanai T., Kato Y., and Miyano T. Effect of antibacterial cathelicidin peptide CAP18/LL-37 on sepsis in neonatal rats. Pediatr. Surg. Int. 21 (2005) 20-24
165. Chertov O., Michiel D.F., Xu L., Wang J.M., Tani K., Murphy W.J., Longo D.L., Taub D.D., and Oppenheim J.J. Identification of defensin-1, defensin-2, and CAP37/Azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271 (1996) 2935-2940
166. Chertov O., Ueda H., Xu L.L., Tani K., Murphy W.J., Wang J.M., Howard O.M.Z., Sayers T.J., and Oppenheim J.J. Identification of human neutrophil-derived Cathepsin G and Azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J. Exp. Med. 186 (1997) 739-747
167. Yang D., Chen Q., Schmidt A.P., Anderson G.M., Wang J.M., Wooters J., Oppenheim J.J., and Chertov O. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T-cells. J. Exp. Med. 192 (2000) 1069-1074
168. Davidson D.J., Currie A.J., Reid G.S.D., Bowdish D.M.E., MacDonald K.L., Ma R.C., Hancock R.E.W., and Speert D.P. The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J. Immunol. 172 (2004) 1146-1156
169. Niyonsaba F., Someya A., Hirata M., Ogawa H., and Nagaoka I. Evaluation of the effects of peptide antibiotics beta-defensin-1/2 and LL-37 on histamine release and prostaglandin D2 production from mast cells. Eur. J. Immunol. 31 (2001) 1066-1075
170. Niyonsaba F., Iwabuchi K., Someya A., Hirata M., Matsuda H., Ogawa H., and Nagaoka I. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 106 (2002) 20-26
171. Di Nardo A., Vitiello A., and Gallo R.L. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170 (2003) 2274-2278
172. Niyonsaba F., Hirata M., Ogawa H., and Nagaoka I. Epithelial cell-derived antibacterial peptides human beta-defensins and cathelicidin: multifunctional activities on mast cells. Curr. Drug Targets Inflamm. Allergy 2 (2003) 224-231
173. Yang D., Chertov O., and Oppenheim J.J. Participation of mammalian defensins and cathelicidins in antimicrobial immunity: receptors and activities of human defensins and cathelicidins. J. Leukoc. Biol. 69 (2001) 691-697
174. Tjabringa G.S., Aarbiou J., Ninaber D.K., Drijfhout J.W., Sorensen O.E., Borregaard N., Rabe K.F., and Hiemstra P.S. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J. Immunol. 171 (2003) 6690-6696
175. Elssner A., Duncan M., Gavrilin M., and Wewers M.D. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release. J. Immunol. 172 (2004) 4987-4994
176. Braff M.H., Hawkins M.A., Di Nardo A., Lopez-Garcia B., Howell M.D., Wong C., Lin K., Streib J.E., Dorschner R., Leung D.Y.M., and Gallo R.L. Structure-function relationships among human cathelicidin peptides: Dissociation of antimicrobial properties from host immunostimulatory activities. J. Immunol. 174 (2005) 4271-4278
177. Bowdish D.M.E., Davidson D.J., Speert D.P., and Hancock R.E.W. The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes. J. Immunol. 172 (2004) 3758-3765
178. Niyonsaba F., Ushio H., Nagaoka I., Okumura K., and Ogawa H. The human β-defensins (-1,-2,-3,-4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J. Immunol. 175 (2005) 1776-1784
179. Lau Y.E., Rozek A., Scott M.G., Goosney D.L., Davidson D.J., and Hancock R.E.W. Interaction and cellular localization of the human host defense peptide LL-37 with lung epithelial cells. Infect. Immun. 73 (2005) 583-591
180. Lau E.Y., Bowdish D.M.E., Cosseau C., Hancock R.E.W., and Davidson D.J. Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37. Am. J. Respir. Cell Mol. Biol. 34 (2006) 399-409
181. Sandgren S., Wittrup A., Cheng F., Jönsson M., Eklund E., Busch S., and Belting M. The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J. Biol. Chem. 279 (2004) 17951-17956
182. Sorensen O.E., Cowland J.B., Theilgaard-Mönch K., Liu L., Ganz T., and Borregaard N. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J. Immunol. 170 (2003) 5583-5589
183. Tokumaru S., Sayama K., Shirakata Y., Komatsuzawa H., Ouhara K., Hanakawa Y., Yahata Y., Dai X., Tohyama M., Nagai H., Yang L., Higashiyama S., Yoshimura A., Sugai M., and Hashimoto K. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J. Immunol. 175 (2005) 4662-4668
184. Borregaard N., Theilgaard-Mönch K., Cowland J.B., Stahle M., and Sorensen O.E. Neutrophils and keratinocytes in innate immunity-cooperative actions to provide antimicrobial defense at the right time and place. J. Leukoc. Biol. 77 (2005) 439-443
185. Shaykhiev R., Beisswenger C., Kändler K., Senske J., Püchner A., Damm T., Behr J., and Bals R. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am. J. Physiol.: Lung Cell. Mol. Physiol. 289 (2005) L842-L848
186. Koczulla R., von Degenfeld G., Kupatt C., Krotz F., Zahler S., Gloe T., Issbrucker K., Unterberger P., Zaiou M., Lebherz C., Karl A., Raake P., Pfosser A., Boekstegers P., Welsch U., Hiemstra P.S., Vogelmeier C., Gallo R.L., Clauss M., and Bals R. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111 (2003) 1665-1672
187. Li J., Post M., Volk R., Gao Y., Li M., Metais C., Sato K., Tsai J., Aird W., Rosenberg R.D., Hampton T.G., Li J., Sellke F., Carmeliet P., and Simons M. PR39, a peptide regulator of angiogenesis. Nat. Med. 6 (2000) 49-55
188. Baldwin R.L. How Hofmeister ion interactions affect protein stability. Biophys. J. 71 (1996) 2056-2063
189. Lohner K., and Blondelle S.E. Molecular mechanism of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics. Comb. Chem. High Throughput Screen. 8 (2005) 241-256
190. Neville F., Cahuzac M., Konovalov O., Ishitsuka Y., Lee K.Y.C., Kuzmenko I., Kale G.M., and Gidalevitz D. Lipid head group discrimination by antimicrobial peptide LL-37: Insight into mechanism of action. Biophys. J. 90 (2006) 1275-1287
191. Toke O., Maloy W.L., Kim S.J., Blazyk J., and Schaefer J. Secondary structure and lipid contact of a peptide antibiotic in phospholipid bilayers by REDOR. Biophys. J. 87 (2004) 662-674
192. Toke O., O'Connor R.D., Weldeghiorhis T.K., Maloy W.L., Glaser R.W., Ulrich A.S., and Schaefer J. Structure of (KIAGKIA)3 aggregates in phospholipid bilayers by solid-state NMR. Biophys. J. 87 (2004) 675-687
193. 19F-NMR. Biophys. J. 88 (2005) 3392-3397
194. Henzler Wildman K.A., Lee D.-K., and Ramamoorthy A. Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry 42 (2003) 6558
195. Ramamoorthy A., Wei Y., and Lee D.K. PISEMA Solid-State NMR Spectroscopy. Annu. Rep. NMR Spectrosc. 52 (2004) 1-52
196. Yamamoto K., Lee D.K., and Ramamoorthy A. Broadband-PISEMA Solid-State NMR Spectroscopy. Chem. Phys. Lett. 407 (2005) 289-293
197. Yamamoto K., Dvinskikh S.V., and Ramamoorthy A. Measurement of heteronuclear dipolar couplings using a rotating frame solid-state NMR experiment. Chem. Phys. Lett. 419 (2006) 533-536
198. Henzler Wildman K.A., Martinez G.V., Brown M.F., and Ramamoorthy A. Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. Biochemistry 43 (2004) 8459-8469
199. Latal A., Degovics G., Epand R.F., Epand R.M., and Lohner K. Structural aspects of the interaction of peptidyl-glycylleucine-carboxyamide, a highly potent antimicrobial peptide from frog skin, with lipids. Eur. J. Biochem. 248 (1997) 938-946
200. Lohner K., and Prenner E.J. Differential scanning calorimetry and X-ray diffraction studies of the specificity of the interaction of antimicrobial peptides with membrane-mimetic systems. Biochim. Biophys. Acta 1462 (1999) 141-156
201. Hallock K.J., Lee D.-K., Omnaas J., Mosberg H.I., and Ramamoorthy A. Membrane composition determines pardaxin's mechanism of lipid bilayer disruption. Biophys. J. 83 (2002) 1004-1013
202. Epand R.F., Ramamoorthy A., and Epand R.M. Membrane lipid composition and the interaction with Pardaxin: the role of cholesterol. Prot. Peptide Letters 13 (2006) 1-5
203. Isogai E., Isogai H., Matuo K., Hirose K., Kowashi Y., Okumura K., and Hirata M. Sensitivity of genera Porphyromonas and Prevotella to the bactericidal action of C-terminal domain of human CAP18 and its analogues. Oral Microbiol. Immunol. 18 (2003) 329-332
204. Isogai E., Hirata M., Isogai H., Matuo K., Kimura K., Yokota K., Oguma K., Tojo M., Kaneko F., Kotake S., and Ohno S. Antimicrobial activity of synthetic human CAP18 peptides to Streptococcus sanguis isolated from patients with Behcet's disease. Adv. Exp. Med. Biol. 528 (2003) 195-200
205. Okumura K., Itoh A., Isogai E., Hirose K., Hosokawa Y., Abiko Y., Shibata T., Hirata M., and Isogai H. C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells. Cancer Lett. 212 (2004) 185-194
206. Nagaoka I., Kuwahara-Arai K., Tamura H., Hiramatsu K., and Hirata M. Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substituents. Inflamm. Res. 54 (2005) 66-73
207. Ciornei C.D., Sigurdardóttir T., Schmidtchen A., and Bodelsson M. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob. Agents Chemother. 49 (2005) 2845-2850
208. Andersson E., Rydengård V., Sonesson A., Mörgelin M., Björck L., and Schmidtchen A. Antimicrobial activities of heparin-binding peptides. Eur. J. Biochem. 271 (2004) 1219-1226
209. Nell M.J., Tjabringa G.S., Wafelman A.R., Verrijk R., Hiemstra P.S., Drijfhout J.W., and Grote J.J. Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application. Peptides 27 (2006) 649-660
210. J6-1 DNA vaccine. Leuk. Res. 29 (2005) 535-543
211. Buffy J.J., Waring A.J., Lehrer R.I., and Hong M. Immobilization and aggregation of the antimicrobial peptide protegrin-1 in lipid bilayers investigated by solid-state NMR. Biochemistry 42 (2003) 13725-13734
212. Tang M., Waring A.J., and Hong M. Intermolecular packing and alignment in an ordered β-hairpin antimicrobial peptide aggregate from 2D solid-state NMR. J. Am. Chem. Soc. 127 (2005) 13919-13927
213. Bak M., Schultz R., Vosegaard Th., and Nielsen N.C. Specification and visualization of anisotropic interaction tensors in polypeptides and numerical simulations in biological solid-state NMR. J. Magn. Reson. 154 (2002) 28-45